Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The heme polymerization machinery is a critical detoxification process within the digestive vacuole of Plasmodium falciparum, the causative agent of malaria. During the intraerythrocytic stage, the parasite ingests and degrades host hemoglobin to obtain essential amino acids, a process that releases large quantities of free heme (ferriprotoporphyrin IX). Because free heme is highly toxic and can cause oxidative damage to membranes and proteins, the parasite converts it into an insoluble, inert crystalline polymer known as hemozoin, or malaria pigment. This biocrystallization is facilitated by specific proteins, such as Heme Detoxification Protein (HDP) and Histidine-Rich Proteins (HRPs), as well as lipid environments within the vacuole (Jani et al., 2008, J Biol Chem; Pisciotta et al., 2007, Biochem J). Many classic antimalarial drugs, particularly the 4-aminoquinolines like chloroquine, exert their therapeutic effect by binding to heme monomers or the growing crystal surface, thereby preventing further polymerization (Slater and Cerami, 1992, Nature). The resulting accumulation of toxic free heme leads to the destruction of the parasite's membranes and eventual cell death (Egan, 2008, Drug Des Devel Ther). This machinery remains one of the most validated and successful targets in antimalarial drug development.
Inhibition of heme biocrystallization into hemozoin, resulting in the accumulation of toxic free ferriprotoporphyrin IX which causes oxidative damage and parasite death (Slater and Cerami, 1992, Nature; Egan, 2008, Drug Des Devel Ther).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme polymerization machinery.